603079.SH
Zhejiang Shengda Bio-Pharm Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 11.76
+0.00%Oct 15, 2026, 09:03 UTC
Shengda Bio reported that it had repurchased 929,600 shares, or 0.49% of its total share capital, for a total of RMB 10.9021 million.
Source:Jul 7, 2026, 07:56 UTC
Shengda Bio appointed Lin Weiyuan as board secretary and Mi Yexuan as securities affairs representative on July 6, 2026.
Source: